Sign in or Register

Already a member?

Sign in

Or sign in with your account on:

Not a member yet?



Sangamo BioSciences (SGMO) Hits 10-Year High on Deal with Biogen (BIIB)

By  +Follow January 9, 2014 12:51PM
Tickers Mentioned:

Shares in Richmond, CA-based clinical stage biopharmaceutical company Sangamo BioSciences (SGMO) spiked nearly 35 percent on Thursday on news of a partnership with Biogen Idec (BIIB) to develop treatments for disorders affecting hemoglobin.

Biogen made an initial payment of $20 million to Sangamo as part of a deal that will total some $300 million in funding as well as double-digit royalties for Sangamo.

Lucrative Deal Drives SGMO to 10-Year High

On the whole, the size and generosity of the deal appear to make this a major win for Sangamo.

"The deal terms are very lucrative for a pre-clinical platform,” said Wedbush analyst Liana Moussatos. “So I think Biogen must have been impressed with the pre-clinical data that Sangamo presented last month."

The spike drove Sangamo to close to $19 a share, its highest level since 2001. It also passed the previous five-year high the company reached when shares were touching $18.50 in 2007.

Hemoglobin Disorders Affect Blood’s Ability to Carry Oxygen

Hemoglobin is the component of blood that carries oxygen, and disorders affecting hemoglobin include sickle cell disease and beta thalassemia. Both are very serious conditions and included in the category known as hemoglobinopathies.

Sangamo has developed technology to replace defective genes in patients with a corrective one, and Biogen appears to believe that this method has the potential to create one treatment for both diseases.

Sangamo will be responsible for research and development of the treatment up to the initial proof-of-concept trial.

SGMO Product Pipeline Could Have Potential

While Thursday’s announced partnership clearly took Sangamo to new levels, boosting the company’s market cap from $843.57 million to almost $1.15 billion in a matter of hours, the company has several treatments in its product pipeline that could also be major developments.

Most notable is lead therapy SB-728, which has the potential to develop into a functional cure for HIV/AIDS. The treatment would function by drawing immune cells, removing the protein pathway used by HIV to infect them, and then returning them to the patient’s bloodstream.

Sangamo’s promise appears to have won over investors, with the stock jumping over 130 percent despite the company failing to turn a profit and garnering revenues under $25 million in each of the last five years.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer

Liked What You Read? Join Equities.com and Connect With Your Favorite Financial Experts FOR FREE! Members of Equities.com gain access to our leading financial news and content, active social investment community, proprietary research tools including the 2014 Small-Cap Stars, E.V.A. reports and more.

Results for SGMO
Robert Zhang
3 Aug 15 05:26:55
Kristina Duering
3 Aug 15 04:21:57
3 Aug 15 04:09:50
3 Aug 15 01:28:22
biotech 2050
2 Aug 15 23:37:45
2 Aug 15 18:00:03
$SGMO Institutional ownership up 4.27% Q/Q, with 2,397,620 net purchase http://t.co/ZgqmvYbGVq http://t.co/MHut3QBdM8
2 Aug 15 15:52:24
WBA Walgreens Boots Alliance, Inc. Short Sales http://t.co/7nAiZbrYiZ $WBA $JNK $SGMO $GDX #WBA #pennystocks #invest
2 Aug 15 15:51:03
XLP Consumer Staples Select Sector SPDR Summary http://t.co/L61eeJUyEa $XLP $EWY $CYBR $SGMO #XLP #stock #stock
2 Aug 15 15:49:06
SGMO Sangamo BioSciences, Inc. Investor Opinions http://t.co/BaaaJiTvRa $SGMO $DIS $EWY $AAPL #SGMO #stock #fin… http://t.co/XG5hVFJGig
2 Aug 15 15:48:04
TRN Trinity Industries Inc. Message Board Posts http://t.co/TuIpdy29yW $TRN $SGMO $CHIQ $XHB #TRN #finance #stock
2 Aug 15 15:47:35
SGMO Sangamo BioSciences, Inc. Stock Message Board http://t.co/a2P9mrjqSq $SGMO $FSAGX $NUGT $TNA #SGMO #invest #stock
2 Aug 15 15:47:10
SGMO Sangamo BioSciences, Inc. News http://t.co/7tk6KPMcFh $SGMO $SBUX $ILNS $ABMD #SGMO #stock #pennystocks
2 Aug 15 15:47:10
SGMO Sangamo BioSciences, Inc. Investor Opinions http://t.co/FX0wiS41S4 $SGMO $DIS $EWY $AAPL #SGMO #stock #finance
2 Aug 15 15:39:36
FOLD Amicus Therapeutics, Inc. Company Info http://t.co/p3mdmzjaCr $FOLD $BLTA $SGMO $CVEO #FOLD #investing #share
2 Aug 15 15:38:14
ERX Direxion Daily Energy Bull 3x Shares Dividend http://t.co/pJ0FiO1jO0 $ERX $IEF $SGMO $DIA #ERX #finance #stock
2 Aug 15 15:36:08
COF Capital One Fncl Corp. Financials http://t.co/ESvq9hwObD $COF $ELTP $DUST $SGMO #COF #stocks #nasdaq
2 Aug 15 15:35:45
CYNO Cynosure, Inc. Shares http://t.co/awx9pckllK $CYNO $FTNT $SGMO $GLD #CYNO #finance #stock
IH News Desk
2 Aug 15 15:35:35
CVX Chevron Corp. Open http://t.co/joA2QU6dUi $CVX $SBUX $SGMO $SHOP #CVX #pennystocks #stock
Lucky Jimmy
2 Aug 15 15:35:35
CYNO Cynosure, Inc. Shares http://t.co/PosGcliFuO $CYNO $FTNT $SGMO $GLD #CYNO #finance #stock
Rosner Stocks
2 Aug 15 15:34:05
AMBA Ambarella, Inc. Exchange http://t.co/0ug8RGtIA8 $AMBA $DBVT $SGMO $GOOG #AMBA #investing #investing
2 Aug 15 15:33:40
AUY Yamana Gold Inc. 52Wk High http://t.co/HbneMp8rmr $AUY $SGMO $USO $COF #AUY #share #stock
2 Aug 15 04:15:42
$SGMO ER on 8/5 After Close. SP were DOWN 14 times out of last 22 qtrs (63%) in Earnings reactions http://t.co/p8lXuhh0bQ
Rosner Stocks
1 Aug 15 23:45:32
SGMO Sangamo BioSciences, Inc. % Change http://t.co/TzqdAtO9sy $SGMO $HERO $WFM $XLK #SGMO #investing #investing
1 Aug 15 23:45:32
SMDD ProShares UltraPro Short MidCap400 Last Trade http://t.co/38Y3umY0qg $SMDD $DDM $BAX $SGMO #SMDD #stocks #stockmarket
1 Aug 15 23:41:07
IBM International Business Machines Day Low http://t.co/ChOn0UAh5z $IBM $SGMO $DVN $MDSO #IBM #finance #finance
1 Aug 15 23:41:06
IBM International Business Machines Day Low http://t.co/2GKb4VDnYJ $IBM $SGMO $DVN $MDSO #IBM #finance #finance
1 Aug 15 11:14:55
RT @RobertLKruse: Future of TIL therapy? Zinc Finger nuclease KO of PD1 improves function, cells resistant to suppression. $LBIO $SGMO http…
Greg David
1 Aug 15 06:17:58
http://t.co/APzP66vnr4 nailed 22 picks in a row last week. Awesome. Google them. Related: $LGCY $MX $TTMI $ARAY $SGMO $EVEP $BCOV
1 Aug 15 02:44:03
SGMO Solar3D, Inc. Prev Close http://t.co/XXyMB0hqwR $SGMO $KO $BABA $EROS #SGMO #pennystocks #stocks
1 Aug 15 02:34:34
CAT Caterpillar, Inc. Change http://t.co/SS3ojjLocT $CAT $CCOI $SGMO $GOOGL #CAT #stock #pennystocks
31 Jul 15 22:31:47
RT @Drchik23: @Sport234a What is there for $biib or $gild to buy? Not much out there IMO. $sgmo $icpt $atln Or take some much riskier bets:…
Robert Kruse
31 Jul 15 07:32:57
Future of TIL therapy? Zinc Finger nuclease KO of PD1 improves function, cells resistant to suppression. $LBIO $SGMO http://t.co/aqsiKlfxRu
30 Jul 15 17:03:44
$SGMO Event Reminder for Sangamo BioSciences, Inc. From our Stock News Alerts App
Capital Market Labs
30 Jul 15 14:54:15
Technical Collapse -> http://t.co/bioo7w0OcG $SGMO Down -1.23% to New Low http://t.co/5z4S81rAvg
30 Jul 15 11:05:02
$SGMO Institutional ownership up 4.27% Q/Q, with 2,397,620 net purchase http://t.co/ZgqmvYbGVq http://t.co/1kyz3KQXhL
30 Jul 15 09:32:04
$SGMO Earnings result is already out. Check out historical price reaction after ER. http://t.co/AMYoQNjbjh
Capital Market Labs
30 Jul 15 09:07:46
Technical Collapse -> http://t.co/bioo7vJcO6 $SGMO Down -1.01% to New Low http://t.co/rodscsL7D1
30 Jul 15 07:07:33
$NK That was short lived&sell triggered today at $34 after upping stop--for a break even, also sold $SGMO for loss.
Greg David
30 Jul 15 06:13:44
Check out http://t.co/Y1RoKIXsmm. Top rated OTC trading group. Related: $SGMO $EPE $SHO $EXAS $TSL
Solar Melt
29 Jul 15 22:27:06
$SGMO Ugly chart, but appears to be bottoming. Supported by 1144 AUG $10 Calls trading Wednesday at $0.30-$0.35. Open Interest 1258.
Skeptical PhD
29 Jul 15 18:05:56
@jae_w_kim Yup, as much as market might not like it, $SGMO still seems to be only company with HemoA NHP data. I'm waiting for more.
Dean Krauss
29 Jul 15 15:59:26
@SkepticalPhD Just saw your tweet about $SGMO figuring out Bthal/SCD. Are you implying it will be a better product than $BLUE lentiglobin?
Skeptical PhD
29 Jul 15 15:41:46
@vlad33301 @Prof_Dollar $SGMO is actually the only preclinical NHP Hemophilia A data I know of: http://t.co/SsCHZroPfN
Skeptical PhD
29 Jul 15 15:35:00
@vlad33301 @Prof_Dollar is likely farthest along, with I'm assuming $SGMO behind.
29 Jul 15 15:18:02
$SGMO Institutional ownership up 4.27% Q/Q, with 2,397,620 net purchase http://t.co/ZgqmvYbGVq http://t.co/XhoyzTg75W
29 Jul 15 13:36:16
$SGMO http://t.co/gKPv9uTUng ER CC@4:30 5Aug-Disappointing entry&glad cut in half prior to it getting bad-Will listen intently for updates.
MyAllies Trading
29 Jul 15 13:06:17
$SGMO Sangamo BioSciences Announces Second Quarter 2015 Conference Call and Webcast http://t.co/1yQYCc55Gr
29 Jul 15 13:05:56
$SGMO Sangamo BioSciences Announces Second Quarter 2015 Conference Call and Webcast From our Stock News Alerts App
29 Jul 15 13:04:05
$SGMO - Sangamo BioSciences Announces Second Quarter 2015 Conference Call and Webcast http://t.co/3z1DEVxvMI
Capital Market Labs
29 Jul 15 12:18:39
Website -> http://t.co/bioo7w0OcG $SGMO Reports Wednesday, Consensus Est. Rev: $14.933M, EPS: $-0.13 http://t.co/kb7ffLYxoX
By  +Follow January 9, 2014 12:51PM



blog comments powered by Disqus

 Today's Must Reads

Beyond Twitter: 5 Small-Cap Tech Plays Nobody’s Talking About

Will the Fed Continue Its Track Record of Unprecedented Moves?

Facebook versus Google: Who Rules the Internet?

Are These the Worst Business Documentaries on Netflix?

Saving the

Small-Cap Market


Small-cap stocks offer investors many benefits, ranging from higher growth potential to overlooked value opportuni... in Equities.com's Hangs on LockerDome

About us

Equities.com is an advanced financial data portal and social network designed to connect self-directed investors with the world’s most innovative startup and small cap companies. Through our in-depth coverage of small cap markets, comprehensive research and stock valuation reports, state of the art issuer products, and world class events, Equities.com provides the social tools and insight that drive tomorrow’s investment relationships and opportunities.

Market Data powered by QuoteMedia.
Copyright © QuoteMedia. Data delayed 15 minutes unless otherwise indicated. Terms of Use.

Login or Register